Identification and Characterization of Cancer Stem-like Cells from Primary Carcinoma of the Cervix Uteri
Affiliations
Like many other solid tumors, cervical cancer contains a heterogeneous population of cancer cells. Several investigators have identified putative stem cells from solid tumors and cancer cell lines via the capacity to self renew and drive tumor formation. The aim of this study was to identify and characterize a cancer stem-like cell population from primary carcinoma of the cervix uteri. Cervical carcinoma from 19 patients staged I-II following International Federation of Gynecology and Obstetrics (FIGO) criteria were disaggregated and subjected to growth conditions selective for stem cells. Eight of nineteen tumor-derived cultures encompassed stem-like cells capable of self-renewal, extensive proliferation as clonal non-adherent spherical clusters. Cell markers of spheroid were identified as CD44+CK17+. Cell survival assays showed the sphere-forming cells were only 48% inhibited by doxorubicin whereas 78% inhibited by paclitaxel. Chemo-resistance may partly attribute to the exclusive expression of ABC transporter. To investigate the tumorigenicity of these stem-like cells, xenoengraftment of 10(5) dissociated spheroid cells allowed full recapitulation of the original tumor, whereas the same amount of tumor cells without non-adherent spheroid selection remained non-tumorigenic. Stemness properties of these spheroid cells were further established by reverse transcription-PCR and Western blotting, demonstrating the expression of embryonic and adult stemness-related genes (Oct-4, Piwil2, C-myc, Stat3 and Sox2). Based on these findings, we assert that cervical cancer contain a subpopulation of tumor initiating cells with stem-like properties, thus facilitating the approach to therapeutic strategies aimed at eradicating the tumorigenic subpopulation within cervical cancer.
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells.
Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P Biomark Res. 2024; 12(1):15.
PMID: 38303021 PMC: 10836005. DOI: 10.1186/s40364-024-00563-3.
Targeting Cervical Cancer Stem Cells by Phytochemicals.
Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A Curr Med Chem. 2024; 31(32):5222-5254.
PMID: 38288813 DOI: 10.2174/0109298673281823231222065616.
HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells.
Kunnummal M, Raveendran P, Basu B, Rani S, Paul R, Kuppusamy K Cell Oncol (Dordr). 2023; 47(3):917-937.
PMID: 38036929 DOI: 10.1007/s13402-023-00904-8.
Zamulaeva I, Matchuk O, Selivanova E, Mkrtchian L, Yakimova A, Gusarova V Int J Mol Sci. 2023; 24(4).
PMID: 36834676 PMC: 9960894. DOI: 10.3390/ijms24043271.
Molecular mechanisms of long noncoding RNAs associated with cervical cancer radiosensitivity.
Wu S, Zhu H, Wu Y, Wang C, Duan X, Xu T Front Genet. 2023; 13:1093549.
PMID: 36685972 PMC: 9846343. DOI: 10.3389/fgene.2022.1093549.